Holger Weis

Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY.

DemeRx, Inc. provides biotechnology services. It focuses on drug addiction among patients coping with chronic pain. The company was founded by Deborah C. Mash on March 1, 2010 and is headquartered in Miami, FL.

EnSA Holdings LLC engages in the business of agricultural production and development in the Dominican Republic. The company was founded by Raymond J. Martin in November 2009 and is headquartered in Fort Lauderdale, FL.

NovaVision, Inc., headquartered in Boca Raton, Fla., researches, develops and provides scientifically based, innovative medical technologies to restore the vision of patients with neurological visual loss. NovaVision's Vision Restoration Therapy (VRT) devices work by enhancing neuroplasticity - the brain's ability to adapt and form new connections to overcome injury. NovaVision's VRT devices map areas where vision may be improved and then provide neurostimulation to the appropriate region within the brain's vision-processing areas. Once only available at select medical centers, VRT can now be prescribed by any neurologist, neuro-ophthalmologist, ophthalmologist, optometrist, physiatrists and continues to be recommended by leading neurological, eye and rehab centers nationwide.

GMP Cos., Inc. develops pharmaceuticals, diagnostic products, and medical devices. The firm is also working on treatments for diabetes, glaucoma, and spinal cord injuries. The company was founded in 1999 and is headquartered in Fort Lauderdale, FL

Jupiter Neurosciences, Inc. is a clinical stage research and development pharmaceutical company. Its therapeutic candidate, JOTROL is applicable to many central nervous system diseases, including Alzheimer’s disease and traumatic brain injury. The company was founded by Christer Rosén, Alexander Rosén, Claes Wahlestedt, Marshall Hayward, and Shaun P. Brothers in June 2015 and is headquartered in Jupiter, FL.